OPKO Health, Inc.: 3.75% convertible notes are convertible ($121,000,000)

What happened The filing says on Oct 1, 2026, OPKO Health, Inc. determined that its 3.75% Convertible Senior Notes due 2029, of which approximately $121,000,000 is outstanding, are convertible by holders through Dec 31, 2026. The filing says the Company has elected to satisfy its conversion obligation under the Notes in shares of the Company’s common stock.

Key details

• The conversion right was triggered because the closing price per share exceeded $1.495, or 130% of the applicable conversion price of $1.15, for at least 20 of 30 consecutive trading days during the quarter ended Sep 30, 2026.
• A holder who elects to convert will receive 869.5652 shares of Common Stock plus any additional shares applicable on the conversion date per $1,000 principal amount under the early conversion provisions in the Indenture dated Jan 9, 2024.
• The Notes will continue to be convertible until Dec 31, 2026, and may be convertible thereafter if one or more conversion conditions in the Indenture are satisfied during future measurement periods.
• U.S. Bank Trust Company, National Association is the trustee and conversion agent for the Notes.

Why it may matter Item 8.01 was reported (other events), describing the triggering of conversion rights under the Indenture and the Company’s election to satisfy conversions in common stock. This filing does not show why the insider traded or why the company acted.